Abstract | RATIONALE: AIM: SAMPLE SIZE: Six hundred and sixty-four patients were included in the study. METHODS AND DESIGN: CLOSE is an academic-driven, multicentre, randomized, open-label, three-group, superiority trial with blinded adjudication of outcome events. The trial has been registered with Clinical Trials Register (Clinicaltrials.gov, NCT00562289). Patient recruitment started in December 2007. Patient follow-up will continue until December 2016. Expected mean follow-up = 5.6 years. STUDY OUTCOMES: The primary efficacy outcome is the occurrence of fatal or nonfatal stroke. Safety outcomes include fatal, life-threatening or major procedure- or device-related complications and fatal, life-threatening or major haemorrhagic complications. DISCUSSION:
|
Authors | Jean-Louis Mas, Geneviève Derumeaux, Pierre Amarenco, Caroline Arquizan, Pierre Aubry, Martine Barthelet, Bernard Bertrand, Eric Brochet, Laure Cabanes, Erwan Donal, Jean-Luc Dubois-Randé, Isabelle Durand-Zaleski, Laura Ernande, Gérard Finet, Alain Fraisse, Maurice Giroud, Patrice Guérin, Gilbert Habib, Jean-Michel Juliard, Didier Leys, Michel Lièvre, Jean-René Lusson, François Marcon, Patrick Michel, Thierry Moulin, François Mounier-Vehier, Luc Pierard, Christophe Piot, Christian Rey, Gilles Rodier, Raymond Roudaut, Jean-Marc Schleich, Emmanuel Teiger, Guillaume Turc, Fabrice Vuillier, Christian Weimar, France Woimant, Gilles Chatellier, CLOSE investigators |
Journal | International journal of stroke : official journal of the International Stroke Society
(Int J Stroke)
Vol. 11
Issue 6
Pg. 724-32
(08 2016)
ISSN: 1747-4949 [Electronic] United States |
PMID | 27056964
(Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial)
|
Copyright | © 2016 World Stroke Organization. |
Chemical References |
- Anticoagulants
- Platelet Aggregation Inhibitors
|
Topics |
- Administration, Oral
- Adolescent
- Adult
- Anticoagulants
(adverse effects, economics, therapeutic use)
- Cardiac Surgical Procedures
(adverse effects, economics)
- Female
- Follow-Up Studies
- Foramen Ovale, Patent
(drug therapy, surgery)
- Humans
- Male
- Middle Aged
- Patient Selection
- Platelet Aggregation Inhibitors
(adverse effects, economics, therapeutic use)
- Postoperative Complications
(economics)
- Secondary Prevention
(economics)
- Stroke
(prevention & control)
- Treatment Outcome
- Young Adult
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|